Testing a new insulin for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This early-stage study tests an investigational insulin (HDV-insulin lispro) given by injection, to see how it affects glucose production in the liver and overall blood sugar control. Participation involves dose-response testing and monitoring, which may help guide future diabetes treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have type 1 diabetes for at least 12 months, and using an insulin pump is preferred but not required.
- Your C-peptide level must be low (a blood test that checks how much insulin your body still makes).
- Your BMI must be between 18 and 33 (a measure of body size).
- Your hemoglobin A1c (a measure of average blood sugar) must be between 6.5% and 8.5%.
- In the last month, you cannot have taken any diabetes pills or non-insulin injections (like SGLT2 inhibitors or GLP-1 agonists), and you cannot have smoked or used nicotine products in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to give insulin directly into the abdomen (intraperitoneal) for people with type 1 diabetes. It will check how safe and effective a single dose is over 12 hours, using a special procedure to keep blood sugar stable (clamp).
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new drug called SAB-142, which aims to stop the immune system from attacking insulin-making cells in type 1 diabetes. It may help preserve your body's ability to make insulin. The trial will check if the drug is safe and effective.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.